Company intelligence
Eye2Gene
We combine imaging and genomics to accelerate diagnosis and development of therapies for eye diseases.
Software Development
London, GB
13 employees
Founded 2026
2 public signals
About Eye2Gene
Eye2Gene is an AI-powered precision ophthalmology platform combining imaging and genomics to accelerate diagnosis and therapy development for eye diseases. We enable pharma and eyecare professionals to make data-driven decisions for patient benefit, getting sight saving treatments to patients earlier. By integrating retinal imaging with genomic analysis, we aim to reduce the diagnostic odyssey patients face from an average of 5 years to a matter of weeks.
Verified activity
Signals from Eye2Gene
2 published signals